Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation

Published:2022-05-02 Issue:5 Volume:13 Page:12350-12364
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Yifan¹²³,Hu Xvlei¹³,Li Hailiang¹,Yao Jian¹²³,Yang Ping¹²³,Lan Yuanxiang¹²³,Xia Hechun²³^ORCID

Affiliation:

1. School of Clinical Medicine, Ningxia Medical University, Yinchuan, China

2. Ningxia Human Stem Cell Institute, General Hospital of Ningxia Medical University, Yinchuan, China

3. Department of Neurosurgery, Ningxia Human Stem Cell Institute, General Hospital of Ningxia Medical University, Yinchuan, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2074107

Reference39 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016

2. Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries

3. Current state and future perspective of drug repurposing in malignant glioma

4. Immunotherapy for glioma: Current management and future application

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock;npj Precision Oncology;2024-02-20

2. Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation;BMC Cancer;2022-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3